RE:RE:RE:RE:RE:Q about BTDI agree with Enrique, we are close to submiting the application for Break through designation. I tried to gather some info from the FDA web page re BTD application process. Appears straightforward. The qualifer would be a significant "UNMET Demand" should exist for this type of cure or treatment. I believe TLT would meet this criteria of unmet demand and the efficacy is already proven, except that we need to wait for a few more patients to cross over from Pending to Partial and Complete recovery.
I for one am going to take a break and sit tight for now and not worry about stock price fluctuations. I expect by Spring 2022 we should be well on our way to be proven winner and may even reach a point by Summer of 2022 that we will no longer be a Penny stock!!. The major move will come when TLT trading volume goes up and gets listed in the TSX instead of the Venture exchange..